These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 36654385

  • 1. MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis.
    Xiang L, Zeng Q, Liu J, Xiao M, He D, Zhang Q, Xie D, Deng M, Zhu Y, Liu Y, Bo H, Liu X, Zhou M, Xiong W, Zhou Y, Zhou J, Li X, Cao K.
    Sci Bull (Beijing); 2021 Sep 15; 66(17):1773-1788. PubMed ID: 36654385
    [Abstract] [Full Text] [Related]

  • 2. MAFG-AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma.
    Xiao M, Liu J, Xiang L, Zhao K, He D, Zeng Q, Zhang Q, Xie D, Deng M, Zhu Y, Zhang Y, Liu Y, Bo H, Liu X, Chen X, Gong L, Bao Y, Hu Y, Cheng Y, Deng L, Zhu R, Xing X, Zhou M, Xiong W, Zhou Y, Zhou J, Li X, Cao K.
    Clin Transl Med; 2020 Dec 15; 10(8):e241. PubMed ID: 33377647
    [Abstract] [Full Text] [Related]

  • 3. Carcinogenic roles of MAFG-AS1 in human cancers.
    Ahmadi M, Morshedzadeh F, Ghaderian SMH, Mousavi P, Habibipour L, Peymani M, Abbaszadegan MR, Ghafouri-Fard S.
    Clin Transl Oncol; 2024 Jan 15; 26(1):52-68. PubMed ID: 37351806
    [Abstract] [Full Text] [Related]

  • 4. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D, Zhong S, Zhu Z, Jiang X, Zhang J, Gu J, Chen F.
    Pathobiology; 2020 Jan 15; 87(6):345-355. PubMed ID: 33238264
    [Abstract] [Full Text] [Related]

  • 5. LncRNA MAFG-AS1 is involved in human cancer progression.
    Li P, Ma X, Gu X.
    Eur J Med Res; 2023 Nov 08; 28(1):497. PubMed ID: 37941063
    [Abstract] [Full Text] [Related]

  • 6. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
    Feng J, Wen T, Li Z, Feng L, Zhou L, Yang Z, Xu L, Shi S, Hou K, Shen J, Han X, Teng Y.
    Aging (Albany NY); 2020 Oct 24; 12(20):20658-20683. PubMed ID: 33098638
    [Abstract] [Full Text] [Related]

  • 7. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
    Li H, Zhang GY, Pan CH, Zhang XY, Su XY.
    Eur Rev Med Pharmacol Sci; 2019 Apr 24; 23(7):2838-2846. PubMed ID: 31002134
    [Abstract] [Full Text] [Related]

  • 8. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
    Jia YC, Wang JY, Liu YY, Li B, Guo H, Zang AM.
    Cell Biol Int; 2019 Apr 24; 43(4):384-393. PubMed ID: 30599080
    [Abstract] [Full Text] [Related]

  • 9. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA.
    Zhang F, Li Y, Gan L, Tong X, Qi D, Wang Q, Ye X.
    FASEB J; 2021 May 24; 35(5):e21529. PubMed ID: 33813778
    [Abstract] [Full Text] [Related]

  • 10. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C, Wu Y, Wang X, Chen K, Tang Z, Guo X.
    Hum Cell; 2021 Mar 24; 34(2):588-597. PubMed ID: 33400245
    [Abstract] [Full Text] [Related]

  • 11. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
    Wu Q, Jiang J.
    Mol Biotechnol; 2022 Sep 24; 64(9):970-983. PubMed ID: 35275356
    [Abstract] [Full Text] [Related]

  • 12. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
    Li C, Wu R, Xing Y.
    Cell Cycle; 2020 Mar 24; 19(5):601-609. PubMed ID: 32079456
    [Abstract] [Full Text] [Related]

  • 13. MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species.
    Vera-Puente O, Rodriguez-Antolin C, Salgado-Figueroa A, Michalska P, Pernia O, Reid BM, Rosas R, Garcia-Guede A, SacristÁn S, Jimenez J, Esteban-Rodriguez I, Martin ME, Sellers TA, León R, Gonzalez VM, De Castro J, Ibanez de Caceres I.
    Transl Res; 2018 Oct 24; 200():1-17. PubMed ID: 30053382
    [Abstract] [Full Text] [Related]

  • 14. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
    Bai Y, Ren C, Wang B, Xue J, Li F, Liu J, Yang L.
    Cancer Gene Ther; 2022 Mar 24; 29(3-4):277-291. PubMed ID: 34035482
    [Abstract] [Full Text] [Related]

  • 15. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
    Cui S, Yang X, Zhang L, Zhao Y, Yan W.
    Biochem Biophys Res Commun; 2018 Nov 17; 506(1):251-258. PubMed ID: 30348529
    [Abstract] [Full Text] [Related]

  • 16. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
    Sui Y, Lin G, Zheng Y, Huang W.
    Eur J Pharmacol; 2019 Sep 15; 859():172465. PubMed ID: 31211984
    [Abstract] [Full Text] [Related]

  • 17. A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis.
    Dabbaghi KG, Mashatan N, Faraz O, Bashkandi AH, Shomoossi N, Tabnak P.
    Pathol Res Pract; 2023 Mar 15; 243():154348. PubMed ID: 36736142
    [Abstract] [Full Text] [Related]

  • 18. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
    Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, Qin JX, Wang GY, Zhang XM, Xia T, Liang Q, Zhao Y, Li R, Zhang SQ, Zhang JH, Chen JG, Wang GC, Chen ZS, Han CH.
    Mol Cancer; 2022 Feb 07; 21(1):37. PubMed ID: 35130920
    [Abstract] [Full Text] [Related]

  • 19. LncRNA MAFG-AS1 Upregulates Polo-Like Kinase-1 by Sponging miR-505 to Promote Gastric Adenocarcinoma Cell Proliferation.
    Fu Y, Wen J, Li X, Gong M, Guo Z, Wang G.
    Crit Rev Eukaryot Gene Expr; 2021 Feb 07; 31(5):27-32. PubMed ID: 34591387
    [Abstract] [Full Text] [Related]

  • 20. TGFBR3 co-downregulated with GATA3 is associated with methylation of the GATA3 gene in bladder urothelial carcinoma.
    Liu XL, Xue BX, Lei Z, Yang DR, Zhang QC, Shan YX, Zhang HT.
    Anat Rec (Hoboken); 2013 Nov 07; 296(11):1717-23. PubMed ID: 24124001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.